KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Equity Ratio: 2020-2025

Historic Equity Ratio for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to 0.47.

  • Ginkgo Bioworks Holdings' Equity Ratio fell 12.64% to 0.47 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.47, marking a year-over-year decrease of 12.64%. This contributed to the annual value of 0.52 for FY2024, which is 21.09% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Equity Ratio of 0.47 as of Q3 2025, which was down 5.46% from 0.50 recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Equity Ratio high stood at 0.79 for Q2 2022, and its period low was 0.21 during Q2 2021.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Equity Ratio value was 0.54 (recorded in 2024), while the average stood at 0.57.
  • Its Equity Ratio has fluctuated over the past 5 years, first surged by 282.47% in 2022, then dropped by 21.86% in 2024.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Equity Ratio (Quarterly) stood at 0.76 in 2021, then dropped by 9.65% to 0.68 in 2022, then decreased by 3.65% to 0.66 in 2023, then decreased by 21.09% to 0.52 in 2024, then dropped by 12.64% to 0.47 in 2025.
  • Its last three reported values are 0.47 in Q3 2025, 0.50 for Q2 2025, and 0.50 during Q1 2025.